KLRA

Kailera Therapeutics

17.94

-0.03-0.17%

After Hours: 17.94 0.00 0.00%19:34 08/14 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE17.81/17.83

TODAY RANGE17.66-18.50

VOL2.08M

MARKET CAP2.38B

52 WEEK RANGE16.39-28.23

AVG VOL (3M)712.87K

% TURNOVER1.60%

TURNOVER--

P/E (TTM)-28.7282

% RANGE4.68%

EPS(TTM)-0.6377

P/E(FORWARD)-4.3240

P/B4.044

BVPS4.530

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP1.62B

SHARES OUTSTANDING129.64M

NEXT EARNINGS--

FREE FLOAT88.28M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

NASDAQ·3d ago
2 GLP-1 Stocks That Could Double Your Money by 2031
TipRanks·5d ago
Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (MDCX) and Kailera Therapeutics, Inc. (KLRA)
TipRanks·6d ago
Analyst Initiates Buy on Kailera, Citing Differentiated Obesity Pipeline and DCF-Based $30 Price Target
TipRanks·6d ago
Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA), Warby Parker (WRBY) and Aprea Therapeutics (APRE)
TipRanks·6d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: P3 Health Partners (PIII) and Kailera Therapeutics, Inc. (KLRA)
Seeking Alpha·08/12 20:56
Kailera Therapeutics, Inc. reports Q2 results
TipRanks·08/11 11:42
Kailera Therapeutics appoints Nur Nicholson as chief technology officer
Dow Jones·08/11 11:00
Press Release: Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer
Seeking Alpha·07/21 12:54
These healthcare stocks are trading near oversold levels as earnings season picks up
Seeking Alpha·07/09 09:00
Kailera Therapeutics: A Second-Wave Obesity Platform With More Than One Way To Win
TipRanks·07/08 13:35
Jefferies Keeps Their Buy Rating on Kailera Therapeutics, Inc. (KLRA)
Dow Jones·07/07 18:14
Kailera Therapeutics Shares Fall After Weight Loss Drug Shows High Rates of Side Effects
Seeking Alpha·07/07 18:08
Obesity drug developer Kalohexis files confidentially for U.S. IPO
TipRanks·07/07 17:30
Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC) and Kailera Therapeutics, Inc. (KLRA)
Seeking Alpha·07/07 15:41
Kailera falls after late-stage trial data for oral GLP-1 candidate

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

-0.24%

866.93

Biogen Inc

BIIB

+1.63%

212.55

Amgen Inc

AMGN

-0.63%

415.21

SHPG

CELG-RT

Lilly Eli & Co

LLY

+0.25%

CELG

Therapeuticsmd Inc

TXMD

-0.48%

2.070

Johnson & Johnson

JNJ

+0.78%

262.37

ABBV

Zoetis Inc

ZTS

-2.70%

73.79

Gilead Sciences Inc

GILD

+0.16%

138.36

Novo-Nordisk A/S

NVO

-1.78%

45.89

Bristol-Myers Squibb Co

BMY

-1.27%

63.83

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

+0.30%

26.87

Sanofi FR

SNY

-0.14%

43.72

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.55%

150.88

Dr Reddys Labs

RDY

-1.18%

12.13

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.